Breaking News Instant updates and real-time market news.

NTEC

Intec Pharma

$7.05

0.2 (2.92%)

, NVS

Novartis

$86.27

0.85 (1.00%)

08:15
01/08/18
01/08
08:15
01/08/18
08:15

Intec Pharma enters Feasibility and Option agreement with Novartis

Intec Pharma (NTEC) announced it has entered into a Feasibility and Option agreement with Novartis Pharmaceuticals (NVS) to explore using the Accordion Pill platform for a proprietary Novartis compound. The details of the therapeutic area or specific compound were not released. Following potentially successful feasibility studies including a Phase 1 PK study, Novartis has the option to enter into negotiations with respect to a potential licensing agreement for employing Intec Pharma Accordion Pill technology.

NTEC

Intec Pharma

$7.05

0.2 (2.92%)

NVS

Novartis

$86.27

0.85 (1.00%)

  • 08

    Jan

  • 08

    Jan

  • 18

    Jan

  • 08

    Feb

  • 16

    Feb

  • 17

    May

NTEC Intec Pharma
$7.05

0.2 (2.92%)

09/21/17
OPCO
09/21/17
NO CHANGE
Target $15
OPCO
Outperform
Intec Pharma price target raised to $15 from $10 at Oppenheimer
Oppenheimer analyst Jay Olson raised his price target for Intec Pharma to $15 from $10 as he is optimistic about the prospects for its clinical assets which rely on the Accordion Pill platform, namely AP-CD/LD for Parkinson's disease and AP-CBD/THC for chronic pain. The analyst reiterates an Outperform rating on the shares.
10/13/17
OPCO
10/13/17
NO CHANGE
Target $15
OPCO
Outperform
Opco more optimistic on Intec Pharma after meeting management
Oppenheimer analyst Jay Olson is "incrementally more optimistic" in his outlook for Intec Pharma after meeting with management. The analyst is "encouraged" by new CEO Jeff Meckler's vision for the Accordion Pill as a platform to unlock significant value for shareholders beyond the current opportunity in Parkinson's disease. Olson maintains an Outperform rating on Intec with a $15 price target.
NVS Novartis
$86.27

0.85 (1.00%)

12/01/17
WELS
12/01/17
NO CHANGE
Target $1525
WELS
Outperform
Amazon price target raised to $1,525 from $1,430 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for Amazon.com (AMZN) to $1,525 to reflect increased outer-year estimates for Web Services as well as a higher sum-of-the-parts valuation. The stock closed yesterday up $15.48 to $1,176.75. The analyst highlights the "very successful" five-day Amazon Wed Services conference in Las Vegas, "record-breaking" early holiday sales data, and another healthcare industry development with CNBC reporting the company is in talks with generic manufacturers Mylan (MYL) and Novartis (NVS). Sena sees an increasing likelihood that Amazon "ultimately becomes a disruptor" in healthcare, with generics representing a potential point of entry. The Wells Fargo Healthcare team sees generics as a "simple entry point" in pharma as it involves many players with ready supply and a price competitive market, Sena tells investors in a research note. The analyst keeps an Outperform rating on Amazon.
12/06/17
BOFA
12/06/17
DOWNGRADE
BOFA
Underperform
Novartis downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Graham Perry downgraded Novartis to Underperform citing recent share strength, Cosentyx competition, and lack of catalysts.
12/13/17
PIPR
12/13/17
NO CHANGE
PIPR
Overweight
Piper calls Regeneron 'essential name to own' in 2018
After spending time with management, Piper Jaffray analyst Christopher Raymond calls Regeneron Pharmaceuticals (REGN) an "essential name to own" in 2018. The analyst believes next year is setting up well for the stock with a "steady stream of meaningful data" and what he expects will be "solid operational upside." The rumors of Eylea's demise are greatly exaggerated, Raymond tells investors in a research note. He notes that management expressed confidence that Eylea's regimen will remain superior to retinal specialists versus Novartis' (NVS) RTH258. Raymond remains a buyer of Regeneron with an Overweight rating and $540 price target. The stock in afternoon trading is up 2%, or $7.78, to $389.50.
01/05/18
NEED
01/05/18
INITIATION
Target $65
NEED
Buy
Juno Therapeutics initiated with a Buy at Needham
Needham analyst Chad Messer initiated Juno Therapeutics (JUNO) with a Buy rating and a price target of $65. Messer says that while Novartis (NVS) and Gilead (GILD) have reached the CAR-T technology market ahead of Juno, the latter is "developing safer and potentially better products", positioning itself with "best-in-class technology". The analyst believes that the selloff in the stock price since the December ASH conference creates an attractive near-term entry point for investors.

TODAY'S FREE FLY STORIES

VIRT

Virtu Financial

$29.10

-0.7 (-2.35%)

05:03
05/23/18
05/23
05:03
05/23/18
05:03
Initiation
Virtu Financial initiated  »

Virtu Financial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRO

Kronos Worldwide

$24.77

-0.165 (-0.66%)

04:59
05/23/18
05/23
04:59
05/23/18
04:59
Upgrade
Kronos Worldwide rating change  »

Kronos Worldwide upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$25.64

0.04 (0.16%)

, JWN

Nordstrom

$45.79

-0.05 (-0.11%)

04:56
05/23/18
05/23
04:56
05/23/18
04:56
Downgrade
DSW, Nordstrom rating change  »

DSW downgraded to Hold…

DSW

DSW

$25.64

0.04 (0.16%)

JWN

Nordstrom

$45.79

-0.05 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

PLAB

Photronics

$9.05

0.6 (7.10%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Photronics to hold an analyst and investor event »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

TMO

Thermo Fisher

$217.88

1.2 (0.55%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Thermo Fisher to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

CAFD

8point3 Energy

$12.19

(0.00%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
8point3 Energy to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

WST

West Pharmaceutical

$90.09

-0.04 (-0.04%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
West Pharmaceutical management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 19

    Jun

FMBI

First Midwest

$26.40

0.25 (0.96%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
First Midwest management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SRDX

Surmodics

$49.10

0.8 (1.66%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Surmodics management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

OTEX

OpenText

$34.21

0.11 (0.32%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
OpenText management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

04:55
05/23/18
05/23
04:55
05/23/18
04:55
General news
Breaking General news story  »

FOMC Minutes to be…

WD

Walker & Dunlop

$56.00

-0.1 (-0.18%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Walker & Dunlop management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 31

    May

WWE

WWE

$56.88

-0.98 (-1.69%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
WWE management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

BMCH

BMC Stock Holdings

$19.75

-0.7 (-3.42%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
BMC Stock Holdings management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

LOGI

Logitech

$40.86

0.15 (0.37%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Logitech management to meet with Citi »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

04:55
05/23/18
05/23
04:55
05/23/18
04:55
General news
Breaking General news story  »

Minneapolis Federal…

MTOR

Meritor

$21.94

-0.2 (-0.90%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Meritor management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 13

    Jun

GGG

Graco

$46.70

-0.64 (-1.35%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Graco management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SSRM

SSR Mining

$10.28

-0.02 (-0.19%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
SSR Mining management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

NVEE

NV5 Global

$60.05

-0.55 (-0.91%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
NV5 Global management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 09

    Jun

  • 12

    Jun

  • 13

    Jun

QTM

Quantum

$3.65

0.025 (0.69%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Quantum management to meet with Lake Street »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

WERN

Werner

$38.30

-0.7 (-1.79%)

, USAK

USA Truck

$23.19

-3.3 (-12.46%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Wolfe Research to hold a conference »

11th Annual Global…

WERN

Werner

$38.30

-0.7 (-1.79%)

USAK

USA Truck

$23.19

-3.3 (-12.46%)

LKQ

LKQ Corp.

$30.14

-0.62 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

  • 13

    Jun

  • 20

    Jun

AGS

PlayAGS

$22.83

-0.21 (-0.91%)

, BYD

Boyd Gaming

$36.45

-0.54 (-1.46%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
SunTrust to hold a bus tour »

Casino Bus tour travels…

AGS

PlayAGS

$22.83

-0.21 (-0.91%)

BYD

Boyd Gaming

$36.45

-0.54 (-1.46%)

CZR

Caesars

$12.65

-0.2 (-1.56%)

RRR

Red Rock Resorts

$34.09

-0.54 (-1.56%)

LGND

Ligand

$187.19

1.95 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

SFBS

ServisFirst

$43.67

-0.01 (-0.02%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
ServisFirst management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

FR

First Industrial Realty

$31.64

0.09 (0.29%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
First Industrial Realty management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.